{
  "docId": "019dd923-622c-750b-8b9a-21918ac10c17",
  "docSlug": "f3db2294dcf9",
  "documentTitle": "Harmony Biosciences (HRMY)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2023-03-28 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 90,
  "pageCount": 366,
  "prevPage": 89,
  "nextPage": 91,
  "slideType": "testimonial",
  "function": "expose_gap",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a Q&A transcript format to validate a negative thesis about the viability of H3 receptor programs.",
  "elementsJson": [
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-21918ac10c17/90",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17#slide-90",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "GSK, I have been monitoring that product for a while, and it has very similar problems, and really, the last I hear from colleagues is that it has been terminated completely.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64d0-7099-9ccf-ccd2d1a71399",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.86,
        "x": 0.07,
        "y": 0.31
      },
      "kind": "list",
      "text": "Q: “And what do you know about the GSK and the J&J H3 receptor programs?”\nA: “GSK, I have been monitoring that product for a while, and it has very similar problems, and really, the last I hear from colleagues is that it has been terminated completely.”\nQ: “Was it very similar to pitolisant and the one you were doing at Abbott?\nA: “Yes.”\nQ: “Did you ever speak to somebody on the GSK program?”\nA: “Yes, I have a couple of friends who were working on that one. It's a small world, specifically neurology.”\nQ: “What did they tell you?”\nA: “I think they, in general, and what we shared was the common methodology of testing and so on. And we had been discussing also passing the blood-brain barrier and how difficult it is. And I think my impression that their finding was very similar to our findings as well.” – Senior pharmaceutical executive/scientist, previously at Abbott and now at another major pharma company",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "da65cca0-ed7d-46e6-89b0-df1da17e42cd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.65,
        "x": 0.07,
        "y": 0.28
      },
      "kind": "paragraph",
      "text": "GSK apparently had a similar H3 receptor program with the same problems and now terminated",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d963be50-2c96-41d1-b08e-a6bd11cc25d8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "I think they, in general, and what we shared was the common methodology of testing and so on. And we had been discussing also passing the blood-brain barrier and how difficult it is. And I think my impression that their finding was very similar to our findings as well. — Senior pharmaceutical executive/scientist, previously at Abbott and now at another major pharma company",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64d0-7099-9ccf-d2e7865decb0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.25,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a0a744d1-1862-47e4-af82-e4ae17f0c046",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "The ex-Abbott scientist indicated the GSK program had “very similar problems” and has been “terminated completely,” based on his conversations with staff there. He stated that “their finding was very similar to our findings” regarding “the blood-brain barrier and how difficult it is.”",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c9024425-a456-490a-a638-0962d281860e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}